Effect of Heparin and/or Antithrombin III on the Generation of Endotoxin-Induced Plasminogen Activator Inhibitor

Summary

It has been experimentally shown that endotoxin induces a significant increase in the blood levels of a plasminogen activator inhibitor (PAI). We evaluated the effect of different doses of heparin (5 to 20IU kg⁻¹ h⁻¹), antithrombin III (10 to 40 U kg⁻¹ h⁻¹ and 240 U/kg as bolus) and of a combination of the two on: 1) the elevation of PAI activity, 2) fibrin deposition in kidneys and 3) mortality in rabbits infused with E. coli lipopoly-saccharide. Our results show that heparin plus AT III is able to significantly reduce the generation of endotoxin-induced PAI activity in rabbits' circulation. Low dose of heparin and a bolus injection of AT III both cause a decrease in the generation of PAI at 2 but not at 6 hours of endotoxin infusion. Moreover, fibrin deposits in kidneys of animals receiving heparin plus AT III or a bolus injection of AT III were significantly reduced as compared to control rabbits. The association between low levels of PAI and decreased fibrin deposits is strengthened by the significant correlation (p < 0.05) found between these two parameters. Finally, the plasma levels of PAI activity at 2 and 6 hours of endotoxin infusion in surviving animals were lower than those observed in animals that died within 2 hours after the end of treatment. We conclude that heparin plus AT III partially prevents the endotoxin-induced generation of PAI activity which seems to correlate with the reduced presence of fibrin deposits in kidneys and with a reduced mortality.

Keywords

Disseminated intravascular coagulation - Endotoxin - Heparin - Antithrombin III - Plasminogen activator inhibitor

• References

• 1 Mizock B. Septic shock. A metabolic perspective. Arch Intern Med 1984; 144: 579-585
• 2 Morrison DC, Ulevitch RJ. The effect of bacterial endotoxins on host mediation systems. A review. Am J Pathol 1978; 93: 526-617
• 3 Bradley SG. Cellular and molecular mechanisms of action of bacterial endotoxins. Annu Rev Microbiol 1979; 33: 67-94
• 4 Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
• 5 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
• 6 Colucci M, Paramo JA, Collen D. Generation in plasma of a fastacting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824
• 7 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
• 8 Juhan-Vague I, Moerman B, de Cock F, Aillaud MF, Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res 1984; 33: 523-530
• 9 Páramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor. Relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemostas 1985; 54: 713-716
• 10 Páramo JA, Colucci M, Collen D, Van de Werf F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J 1985; 291: 573-574
• 11 Páramo JA, De Boer A, Colucci M, Jonker JJ C, Collen D. Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis. Thromb Haemostas 1985; 54: 725
• 12 Rocha E, Alfaro MJ, Páramo JA, Cañadell JM. Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement. Thromb Haemostas 1988; 59: 93-95
• 13 Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 14 Verheijen JH, Mullaart E, Chang GT G, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
• 15 Camacho Y, Navio G, Acosta J, Rocha E. Purification of pasteurized AT-III. Thromb Haemostas 1985; 54: 90 (Abstr).
• 16 Merskey C, Lalezari P, Johnson AJ. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med 1969; 131: 871-875
• 17 Loskutoff DJ, Mussoni L. Interactions between fibrin and the plasminogen activators produced by cultured endothelial cells. Blood 1983; 62: 62-68
• 18 Bergstein JM, Michael AF. Renal cortical fibrinolytic activity in the rabbit following one or two doses of endotoxin. Thromb Diath Haemorrh 1973; 29: 27-32
• 19 Colucci M, Páramo JA, Collen D. Inhibition of one-chain and two- chain forms of human tissue-type plasminogen activator by the fastacting inhibitor of plasminogen activator in vitro and in vivo. J Lab Clin Med 1986; 108: 53-59
• 20 Schwartz BS, Monroe MC, Levin EG. Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide. Blood 1988; 71: 734-741
• 21 Egbring R, Schmidt W, Fuchs G, Havermann K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 1977; 49: 219-231
• 22 Aasen AO, Ohlsson K. Release of granulocyte elastase in lethal canine endotoxin shock. Biol Chem Hoppe-Seyler 1978; 359: 683-690
• 23 Colucci M, Páramo JA, Stassen JM, Collen D. Influence of the fastacting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue type plasminogen activator in rabbits. Interference of tissue-derived components. J Clin Invest 1986; 78: 138-144
• 24 Gelehrter TD, Scnycer-Laszuk R. Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells. J Clin Invest 1986; 77: 165-169
• 25 Colucci M, Triggiani R, Cavallo LG, Semeraro N. Thrombin infusion in endotoxin-treated rabbits reduces the plasma levels of plasminogen activator inhibitor (PAI): evidence for a protein C (PC)-mediated mechanism. Fibrinolysis 1988; 2: 153 (Abstr).